Consolidated manual action for pathology test.
Ended Awarded Last action
- Contract number
- W90VN622F5003
- Awardee
-
Seoul Clinical Laboratories UEI E961H2AE4AN5
- Awarding agency
-
RCO Osan 411th CSB
Expeditionary Contracting Command, Department of Defense
- Obligated
- $1,486
Award facts
- Contract value 1% obligated
-
- $1,485.93 Current, with exercised options
- $150,000.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Pacific Air Forces Air Force, Department of Defense
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South Korea
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Seoul Clinical Laboratories, a for-profit research institute located in South Korea, to provide consolidated manual action for pathology testing services. The contract, valued at $150,000.00, is a firm fixed-price Blanket Purchase Agreement (BPA) call with the Pacific Air Forces (PACAF), a subordinate unified command of the United States Air Force. The contract does not have a set-aside designation and is set to run through February 28, 2026.
Seoul Clinical Laboratories has extensive experience delivering a wide range of medical laboratory services, including COVID-19 testing, to U.S. military treatment facilities and personnel stationed in South Korea. The company holds several significant indefinite delivery vehicles (IDVs) with the Department of Defense, including a $11.3 million single-award IDV with the Army Medical Command for COVID-19 testing and a $250,000 multiple-award BPA with PACAF for pathology testing services. These contract vehicles allow DoD agencies to efficiently procure Seoul Clinical Laboratories' services as needed to support healthcare requirements for U.S. military personnel in the region.
Quick answers
Who was awarded contract W90VN622F5003?
W90VN622F5003 was awarded to Seoul Clinical Laboratories by RCO Osan 411th CSB (Expeditionary Contracting Command) on October 1, 2021.
How much is contract W90VN622F5003 worth?
The government has obligated $1,486 on W90VN622F5003. Its potential value, with all options, is $150,000.
Which agency awarded contract W90VN622F5003?
RCO Osan 411th CSB (Expeditionary Contracting Command) awarded W90VN622F5003, with funding from Pacific Air Forces (Air Force).
Is contract W90VN622F5003 an order under another contract?
Yes. W90VN622F5003 is a BPA call under W90VN621A0006, a blanket purchase agreement.
Was contract W90VN622F5003 competed?
The extent of competition for W90VN622F5003 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award